Showing results (531-540 of 582) with videos related to

Sort By:
Pageof 59
Plos Neglected Tropical Diseases|December 31, 2025
In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 24, 2024
RIP3 regulates doxorubicin-induced intestinal mucositis via FUT2-mediated α-1,2-fucosylationWei Wen, Xiaomin Hu, Jialin Liu, et al.
Plant Biotechnology Journal|July 20, 2024
PhieDBEs: a DBD-containing, PAM-flexible, high-efficiency dual base editor toolbox with wide targeting scope for use in plantsZhiye Zheng, Taoli Liu, Nan Chai, et al.
Plant Communications|June 26, 2025
Programmable genome engineering and gene modifications for plant biodesignJialin Liu, Ruixiang Zhang, Nan Chai, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for TalaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
Neuron|October 17, 2020
Emergence of Neuronal Diversity during Vertebrate Brain DevelopmentBushra Raj, Jeffrey A Farrell, Jialin Liu, et al.
BMC Nursing|August 22, 2025
Associations between perceived stress profiles, social connection and work engagement in clinical registered nurses: a mediation analysis and generalized additive modelsYuan Liao, Miaochun Huang, Zhimin Gu, et al.
Marine Pollution Bulletin|March 2, 2025
Spatial-temporal variations of kelp 129I contents in coastal waters of China before and after the Fukushima Daiichi Nuclear Power Plant accidentXiaowen Liu, Jialin Liu, Yukun Fan, et al.
BMC Medicine|August 27, 2023
Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in ChinaTianqi Tan, Tingting Chen, Wenwen Zhu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 11, 2026
Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancerHongyu Bie, Jiarui Li, Jialin Liu, et al.
Pageof 59